This outcome validates the strength of Rampart’s intellectual property and reflects the real-world innovation embodied in our products.” — Tom Livingston, CEO ...
Rampart Bioscience – a biotechnology company developing next-generation biologics – recently announced an $85 million Series A financing to create medicines to unburden patients from disease and their ...
Veterinarian Dr. Carol Steiner (second from right), her partner Arisa Apodaca (third from right) and their staff pose for a photo in the examination area at the hospital on the first day the facility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results